The Gateway Pundit reported on Tuesday that the Advisory Committee on Immunization Practices (ACIP) under CDC is scheduled to vote today, October 19 on whether or not to include COVID vaccinations in their routine Vaccines for Children (VFC) Program.
The Vaccines For Children (VFC) program is a federally funded program that provides vaccines at no cost to children who might not otherwise be vaccinated because of their inability to pay, according to the CDC.
“The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines,” ACIP said.
“The agenda will include discussions on influenza vaccines, pneumococcal vaccine, meningococcal vaccines, respiratory syncytial virus vaccine, rotavirus vaccine, dengue vaccines, adult immunization schedule, child/adolescent immunization schedule, COVID-19 vaccines and Chikungunya vaccine. Recommendation votes on pneumococcal, adult immunization schedule, child/adolescent immunization schedule and COVID-19 vaccines are scheduled. A Vaccines for Children (VFC) vote on COVID-19 vaccine is scheduled,” it added.
Rep. Thomas Massie (R-KY) stated, “According to an outside lawyer I trust, CDC meeting to add COVID shots to childhood vaccine list will trigger some state requirements to attend schools and play sports. Will also give liability protection to manufacturers.”
The Gateway Pundit was able to download the slides/presentation that will be shown at today’s conference from the ACIP website.
According to the presentation, the vaccination program for the COVID-19 vaccine will include toddlers as young as 6 months old to 17 years old.
For the booster shot, monovalent mRNA vaccines are no longer authorized as booster doses. Only the updated dose (bivalent) is authorized. Only Pfizer-BioNTech bivalent booster is authorized for people age 5 years. Both Pfizer-BioNTech and Moderna bivalent boosters are authorized for people ages 6 years and older.
Mix and match is now authorized. In other words, you can choose between Moderna or Pfizer booster dose regardless of which one you received in the primary series.
Below is the COVID-19 vaccination schedule for children and adolescents who are NOT moderately or severely immunocompromised: (A primary series is the initial dose(s) of a COVID-19 vaccine. For Pfizer and Moderna mRNA vaccines, the primary series is two/three vaccine doses.)
Below is the COVID-19 vaccination schedule for children and adolescents who ARE moderately or severely immunocompromised:
There is a different color cap on each vial that corresponds to each age group.. See below:
The presentation claimed that the benefits of COVID-19 vaccination outweigh the known and potential risks, including the very small risk of myocarditis or pericarditis.
In another presentation, it states that, “COVID-19 vaccines will not be available through the VFC program immediately following the passage of this resolution because they remain available for all Americans under the US Government’s National COVID-19 Response.”